OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Gastroenterology and Hepatology is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	566
Front Cover	464
Hepatic Artery Pseudoaneurysm After Whipple Procedure	359
Table of Contents	302
Blue Notes	258
Editorial Board	241
Blue Notes	239
FODMAPs in IBS: Revisiting Restriction	210
Reply	206
Editorial Board	203
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	193
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	183
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	183
Reply	178
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	153
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	153
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	144
Who Examines the Colon Matters More Than What Is Removed	140
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	139
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	137
Correction	134
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	132
Table of Contents	131
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	130
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	130

Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	129
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	121
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	119
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient in Clinical Practice: An Investigational Procedure—What Can We Tell Patients?	119
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	116
Symptom-Based Testing and Eradication of Helicobacter pylori and Risk of Gastric Cancer	115
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	114
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	110
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	110
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	110
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	104
Front Cover	102
Reply	100
Assessment and Significance of Histologic Activity in Crohn’s Disease	100
Hypermobile Ehlers-Danlos Syndrome and the Nosology of Disorders of Gut-Brain Interaction	99
Blue Notes	97
Association Between Index Adenomas and Advanced Findings at Third Colonoscopy: Data From the New Hampshire Colonoscopy Registry	97
Elsewhere in the AGA Journals	95
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	95
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	95
Hepatic Steatosis Is Associated With Increased Cardiovascular Risk Through Adverse Coronary Plaque Composition	93
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	92
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	91
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	91
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	89
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease	89
Automated deep learning detection of hepatic steatosis on non-contrast CT scans and discrepancy with scan reports	88
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	88
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	87
Update in the Treatment of the Complications of Cirrhosis	87
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	86
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	85
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	83
Optimizing trial design for evaluating combination therapies in IBD	83
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	83
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	82
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	82
Associations Between Sexual Orientation and Disorders of Gut-Brain Interaction in Sexual Minority Populations	81
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	81
AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study	80
Fecal Microbiota-Based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C difficile Infection	79
Chronic Kidney Disease Does Not Influence Response to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury	78
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	78
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	77
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	76
Perianal Disease in Pediatric-Onset Crohn’s Disease: Incidence, Disease Course, and Long-Term Outcomes	75
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	75
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	73
Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial	73